Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NYSE:NVO)'s share was trading at $85.73 as of Dec 30^th. NVO’s trailing and forward P/E were 28.92 and 21.98 respectively according to Yahoo Finance.

[caption id="attachment_1236011" align="aligncenter" width="768"] A researcher in a lab coat working with a microscope, studying a biopharmaceutical drug.[/caption]

Novo Nordisk’s Phase 3 REDEFINE 1 study results for CagriSema have sparked a...